Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alejandro Orozco-Narváez"'
Autor:
Hilda Fragoso-Loyo, Javier Cabiedes, Alejandro Orozco-Narváez, Luis Dávila-Maldonado, Yemil Atisha-Fregoso, Betty Diamond, Luis Llorente, Jorge Sánchez-Guerrero
Publikováno v:
PLoS ONE, Vol 3, Iss 10, p e3347 (2008)
BACKGROUND: Despite the uncertainty in the diagnosis of neuropsychiatric involvement in systemic lupus erythematosus (SLE), attempts have been made to record the association of certain antibodies in serum with neuropsychiatric (NP) manifestations. We
Externí odkaz:
https://doaj.org/article/7235207c2c8f49269ff530698f342280
Autor:
Damaris Vazquez-Guevara, Alejandro Orozco-Narvaez, Hector G. Hernandez-Rodriguez, Francisco Rivas-Ruvalcaba, Juan Manuel Shiguetomi-Medina, Ildefonso Rodriguez-Leyva
Publikováno v:
Exploration of Neuroprotective Therapy, Vol 3, Iss 2, Pp 131-138 (2023)
Aim: To compare the efficacy of memantine with that of valproate as a prophylactic treatment for episodic migraine within three months. The efficacy, safety, and response rate were evaluated. Methods: Prospective, randomized, double-blind, controlle
Externí odkaz:
https://doaj.org/article/6d46d4bc13a9438790eb1da295a1a127
Autor:
Luis Llorente, L Dávila-Maldonado, Y Atisha-Fregoso, Jorge Sánchez-Guerrero, Alejandro Orozco-Narváez, Yvonne Richaud-Patin, Hilda Fragoso-Loyo
Publikováno v:
Arthritis & Rheumatism. 56:1242-1250
Objective To define the cytokine and chemokine profile in cerebrospinal fluid (CSF) from patients with neuropsychiatric systemic lupus erythematosus (NPSLE). Methods Forty-two SLE patients who had been hospitalized because of NP manifestations were s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b098b9ec771ebd728e4c2c3bdde1223e
https://doi.org/10.1002/art.22451
https://doi.org/10.1002/art.22451
Autor:
Jorge Sánchez-Guerrero, Javier Cabiedes, Alejandro Orozco-Narváez, Hilda Fragoso-Loyo, Betty Diamond, Luis Llorente, Yvonne Richaud-Patin
Publikováno v:
Rheumatology (Oxford, England). 48(12)
Sir, The ACR classifies neuropsychiatric (NP) manifestations into 19 syndromes [1]. From a classification perspective, the current approach of attributing NP manifestations in SLE patients may be appropriate; however, from a pathogenic standpoint, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31811cdc5d5ed3c17f3207d82cc20cab
https://pubmed.ncbi.nlm.nih.gov/19755508
https://pubmed.ncbi.nlm.nih.gov/19755508